Gene therapy method may enhance effectiveness of immunotherapy for glioblastoma
Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.
Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
Neuroscience and neuromedicine at UF ranks No. 2 among all public universities in 2023 NIH funding.
Study details novel method to create personalized mRNA-based vaccines to target brain tumors.
Induction honors physicians with outstanding credentials in basic or translational biomedical research.
Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.
American Society for Clinical Investigation award recognizes Dr. Duane Mitchell’s work to develop innovative brain cancer treatments.
Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.
Dr. Carlos Rinaldi-Ramos will lead projects involving Drs. Lan Hoang-Minh and Duane Mitchell, and Drs. Marcelo Febo and Lakeisha Williams.
Preston A. Wells Jr. Center for Brain Tumor Therapy team uses novel approaches to accelerate discoveries in the fight against brain cancer.